Pharmaceutical Technology on MSN
4DMT and Otsuka to advance eye disease treatment in APAC
D-150 delivers a sustained release of anti-vascular endothelial growth factor with one intravitreal injection.
In the face of relentless Chinese competition, some Japanese firms are reassessing their strategies for the ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results